January 2023
1. BALAKRISHNAN B, Gupta A, Basri R, Sharma VM, et al
   Endothelial-Specific Expression of CIDEC Improves High-Fat Diet-Induced Vascular and Metabolic Dysfunction.
   Diabetes. 2023;72:19-32.
   

   >> Share

   
   November 2022
2. HEEBOLL S, Risikesan J, Ringgaard S, Kumarathas I, et al
   Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).
   Diabetes. 2022;71:2402-2411.
   

   >> Share

   
   September 2022
3. RICHTER MM, Galsgaard KD, Elmelund E, Knop FK, et al
   The Liver-alpha-Cell Axis in Health and in Disease.
   Diabetes. 2022;71:1852-1861.
   

   >> Share

   
   August 2022
4. ZHU Z, Wang K, Hao X, Chen L, et al
   Causal Graph Among Serum Lipids and Glycemic Traits: A Mendelian Randomization Study.
   Diabetes. 2022;71:1818-1826.
   

   >> Share

   
   April 2022
5. ROCHFORD JJ
   When Adipose Tissue Lets You Down: Understanding the Functions of Genes Disrupted in Lipodystrophy.
   Diabetes. 2022;71:589-598.
   

   >> Share

   
   November 2021
6. YOUSRI NA, Suhre K, Yassin E, Al-Shakaki A, et al
   Metabolic and Metabo-Clinical Signatures of T2D, Obesity, Retinopathy and Dyslipidemia.
   Diabetes. 2021 Nov 3. pii: db21-0490. doi: 10.2337/db21-0490.
   

   >> Share

   
   May 2021
7. AMARENCO P, Kim JS, Labreuche J, Charles H, et al
   Impact of lower vs higher LDL cholesterol targets on cardiovascular events after ischemic stroke in diabetic patients.
   Diabetes. 2021 May 12. pii: db21-0302. doi: 10.2337/db21-0302.
   

   >> Share

   
   February 2021
8. FERRANNINI E
   A Journey in Diabetes: From Clinical Physiology to Novel Therapeutics: The 2020 Banting Medal for Scientific Achievement Lecture.
   Diabetes. 2021;70:338-346.
   

   >> Share

   
   October 2020
9. KOTHARI V, Bornfeldt KE
   A New Treatment Strategy for Diabetic Dyslipidemia?
   Diabetes. 2020;69:2061-2063.
   

   >> Share

   
   January 2020
10. CASANOVA F, Wood AR, Yaghootkar H, Beaumont RN, et al
    A Mendelian Randomization Study Provides Evidence that Adiposity and Dyslipidemia Lead to Lower Urinary Albumin Creatinine Ratio, a Marker of Microvascular Function.
    Diabetes. 2020 Jan 8. pii: db19-0862. doi: 10.2337/db19-0862.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share